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ABSTRACT
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen commonly associated with nosocomial 
infections. However, it has also been associated with community-acquired skin and soft tissue infections (CA-MRSA). There 
are few data on the identification and prevalence of CA-MRSA infections in Brazil. Methods: This is a cross-sectional study of 
104 patients with community-acquired skin infections attending two health care centers in Porto Alegre, southern Brazil. MRSA 
isolates were characterized by molecular methods, including detection of the mecA gene by PCR, gene SCCmec typing, Panton-
Valentine leukocidin (PVL) detection, pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST). Results: 
From the 104 samples, 58 Staphylococcus aureus isolates were obtained, of which five (8.6%) had a CA-MRSA-resistant profile. 
All five isolates had the mecA gene and amplified to SCCmec type IV. Analysis of chromosomal DNA by PFGE revealed the 
presence of two clusters related to international clones (OSPC and USA 300), with a Dice similarity coefficient >80%. The study 
was complemented by MLST, which detected three different strains: ST30, ST8, and ST45, the latter not presenting any relation 
with the clones compared in PFGE. Conclusions: The presence of CA-MRSA reveals an important change in the epidemiology 
of this pathogen and adds new elements to the knowledge of the molecular biology of infections by MRSA with SCCmec type 
IV in southern Brazil.
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Staphylococcus aureus is a microorganism responsible for 
a wide variety of infectious diseases. The major concern refers 
mainly to methicillin-resistant Staphylococcus aureus (MRSA) 
isolates, which traditionally were limited to the hospital (HA)1. 
However, in recent years, community-acquired methicillin-
resistant Staphylococcus aureus (CA-MRSA) infections have 
been reported worldwide2-5. CA-MRSA isolates frequently 
cause infections involving the skin and soft tissues, such as 
cellulites and abscesses, but they might be responsible for 
severe infections, such as necrotizing pneumonia and fasciitis, 
meningitis, bacteremia, and septic shock6-9.
Infections by CA-MRSA isolates are usually associated 
with children, young adults, and healthy people, particularly 
those living close together or having close physical contact 
with each other. Most reports in the literature refer to athletes of 
team sports, individuals doing military service, prison inmates, 
intravenous drug users, homeless people, and children in day 
care centers as having a higher risk of developing CA-MRSA 
infections. The typical presentation would be a young athlete 
with abscess and cellulites, with contributing factors such as 
physical contact, skin lesions, and sharing of contaminated 
equipment10-13.
Epidemiologically, clinical MRSA isolates are defined as 
CA-MRSA if collected from outpatients or collected up to 48 
hours after hospital admission. However, the time criterion 
should not be considered in patients with risk factors for 
HA-MRSA. Recent hospitalization, use of antimicrobial drugs, 
surgical procedures, use of long-term indwelling catheter or other 
intravascular and cutaneous devices, and admission to nursing 
homes should be excluded14,15. A phenotypic profile of increased 
susceptibility to antimicrobial agents, except to beta-lactams, is a 
commonly observed characteristic. This manifests itself as a lack 
of other resistance genes, except for mecA, in the staphylococcal 
cassette chromosome mec (SCCmec) genomic complex of types 
IV and V representatives, usually associated with community-
acquired infections. SCCmec types IV and V present a smaller 
resistance island when compared to the islands carried by isolated 
clones in nosocomial infections (SCCmec I, II, and III)16-18, which 
usually impart multiresistance to these isolates. 
Panton-Valentine leukocidin (PVL) expression is another 
important genetic characteristic associated with CA-MRSA 
strains. PVL is encoded by luk-PV and lukS-PV genes, and its 
presence in Staphylococcus aureus isolates is associated with 
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METHODS
Bacterial isolates
A cross-sectional study was performed. Staphylococcus 
aureus was originated from skin infections of patients attending 
two reference health care centers in southern Brazil (Sanitary 
Dermatology Outpatient Clinic of Rio Grande do Sul and the 
Emergency Unit of the Complexo Hospitalar Santa Casa de 
Porto Alegre) between September 2007 and March 2008. In 
addition to the clinical diagnosis and the phenotypic and genotypic 
characteristics of the Staphylococcus aureus, the age and gender 
of patients were also evaluated. The inclusion criteria were: 
outpatients or patients admitted to the hospital for up to 48h 
and presence of superficial cutaneous and soft tissue infections. 
The exclusion criteria were: presence of any underlying illness 
possibly predisposing to frequent hospitalizations or frequent 
visits to medical facilities, surgical interventions, presence of 
intravenous catheter or long-term indwelling intravascular 
or cutaneous devices, admission to nursing homes, and 
isolation from other organisms except for Staphylococcus 
aureus. And positive samples in duplicate.
Sample collection
After decontaminating the margins and surface of the lesion 
with physiological saline and 70% alcohol, biological material 
was collected with a sterile swab. The material was sent to the 
Microbiology Laboratory of the Federal University of Health 
Sciences of Porto Alegre, where the standard procedures were 
performed for bacterial isolation and identification of organisms 
present in the lesions.
Phenotypic characterization
The tests used for phenotypic characterization of the 
Staphylococcus aureus were Gram staining, growth and 
fermentation on mannitol agar, coagulase test, and DNase test 
agar.  Staphylococcus aureus ATCC 25923 and Staphylococcus 
epidermidis ATCC 12228 were used as positive and negative 
control, respectively.
Susceptibility test
The antibiotic susceptibility of the strains against the 
antibiotics mentioned below was tested by using the Kirby-
Bauer disk diffusion method. The results of susceptibility 
testing were interpreted according to accepted guidelines21. Disk 
susceptibility testing was carried out using cefoxitin (30µg), 
ciprofloxacin (5μg), clindamycin (2μg), chloramphenicol 
(30μg), erythromycin (15μg), gentamicin (10μg), linezolid 
(30μg), oxacillin (1μg), and trimethoprim-sulfamethoxazole 
(25μg). Resistance to macrolides and lincosamides was assessed 
by D-test, with a distance of 15-26mm between the clindamycin 
(2µg) and erythromycin (15µg) disks, as previously described22. 
Staphylococcus aureus ATCC 25923 was used as quality control 
in the disk diffusion technique.
Molecular characterization
Complete molecular characterization (presence of the mecA 
gene, determination of SCCmec type, detection of the gene lukF, 
PFGE, and MLST) was performed for the MRSA isolates. Gene 
mecA characterization and SCCmec typing were performed by 
multiplex polymerase chain reaction (PCR) assay according to 
the protocol previously developed by Zhang et al.23. To detect the 
PVL-encoding gene, primers were synthesized from genomic 
DNA sequences of the GenBank database (GenBank access 
number AB006796) according to Figueiredo et al.24. Analysis of 
chromosomal deoxyribonucleic acid (DNA) of MRSA isolates 
was performed by pulsed-field gel electrophoresis (PFGE) 
according to the protocol established by the Centers for Disease 
Control and Prevention for Staphylococcus aureus molecular 
typing25. Multilocus sequence typing (MLST) was performed 
by following the procedures in previously published protocols26. 
The sequences of the seven housekeeping genes (arc, aroE, glpF, 
gmk, pta, tpi, and yqiL) were compared to existing sequences in 
the MLST database at http://www.mlst.net for the assignment of 
allelic numbers. Sequence types (ST) were assigned according 
to their allelic profiles.
Ethical considerations
The research was approved by the Ethics Committee in 
Research of the Complexo Hospitalar da Santa Casa de Porto 
Alegre and the Ethics Committee in Health Research of the Escola 
Pública de Saúde do Rio Grande do Sul. To take part in the study, 
each patient or his or her legal representative signed a free and 
informed consent form.
A total of 104 patients, mostly (70.1%) males, were analyzed 
for a period of seven months. With regard to age, 10 (9.6%) 
patients were children, 27 (26%) were between 18 and 39 years 
old, and 67 (64.4%) were aged 40 years or older.
Isolation of Staphylococcus aureus was obtained in 58 
(55.8%) patients with skin and soft tissue infections; five (8.6%) 
S. aureus isolates were resistant to oxacillin and cefoxitin, having 
been characterized as MRSA. These isolates were associated with 
community-acquired infections based on the epidemiological 
characteristics and phenotypic profile of sensitivity. Other 
patients showed negative cultures or growth of different 
organisms. Table 1 shows the resistance profile to antimicrobials 
of the MRSA isolates. Most MRSA were shown to be multi-
susceptible, a phenotypic characteristic observed in isolates 
tissue necrosis and leukocyte destruction by forming pores in 
the cell membrane19. This exotoxin may be detected by searching 
for specific genes by through a polymerase chain reaction. 
CA-MRSA infections are the subject of much concern because the 
microorganism does not respond to the beta-lactam antimicrobial 
agents commonly used to empirically treat various community 
infections20.
The purpose of our study was to characterize Staphylococcus 
aureus isolates from community-acquired skin and soft tissue 
infections in the City of Porto Alegre while searching for 
CA-MRSA. There are few data on the identification and 
prevalence of CA-MRSA infections in Brazil.
RESULTS
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TABLE 1 - Phenotypic and genotypic properties of methicillin-resistant Staphylococcus 
aureus with SCCmec type IV.
  Antibiogram SCCmec PVL- ST
Isolate Isolation date (resistance to) type encoding gene
A31651 09 Oct  2007 CFO, CLI, ERI, OXA IV + 30
A31652 08 Nov 2007 CFO, CIP, ERI, OXA IV - 8
A31655 30 Oct  2007 CFO, OXA IV + 30
A31656 22 Nov2007 CFO, OXA IV + 30
AD554 12 Dec 2007 CFO, CLO, OXA IV - 45
SCCmec: staphylococcal cassette chromosome mec; PVL: Panton-Valentine leukocidin; 
ST: sequence type; CFO: cefoxitin; CIP: ciprofloxacin; CLI: clindamycin; CLO: chloramphenicol; 
ERI: erythromycin; OXA: oxacillin. 
characterized as community-acquired. MRSA isolates (A31651 
and AD554) were obtained from two patients from the community 
(a 39-year-old male and a 54-year-old female, respectively) 
presenting with skin infections (furunculosis). Another 
isolate (A31652) was obtained from the skin infections of a 
3-year-old male who presented with chicken pox wounds. 
FIGURE 1 - Cluster analysis of CA-MRSA samples containing SCCmec type IV compared with international standard samples using Dice similarity coefficient. 
SCCmec: staphylococcal cassette chromosome mec; CA-MRSA: community-acquired methicillin-resistant Staphylococcus aureus.
DISCUSSION
The present study allowed showing the presence of MRSA 
among Staphylococcus aureus isolates characterized as 
community-acquired (CA-MRSA in 8.6% of cases), indicating a 
change in the epidemiology of this organism, as resistant isolates 
were found outside a hospital setting. The findings confirm the 
potential emergence of MRSA in community settings in Porto 
In addition, MRSA isolates (A31655 and A31656) were obtained 
from two outpatients (a 1-month-old female and a 7-year-old 
male, respectively), the first presenting with ocular injury, and 
the second with injury caused by lower-limb trauma, which 
evolved to cellulitis, pneumonia, and sepsis. Following these 
strict criteria, previously suggested by Salgado et al.14 and the 
Centers for Disease Control and Prevention (CDC)15, these five 
isolate cases were defined as representing community-acquired 
infections (CA-MRSA).
Similarly to MRSA, all the characterized samples presented 
an amplification of the themecA gene in the PCR and amplified 
to SCCmec type IV by the Zhang et al.23 method. Among the 
type IV SCCmec samples, three presented an amplification of 
the PVL-encoding gene. The PFGE analysis of chromosomal 
DNA revealed two clusters related to international clones: 
OSPC (Oceania Southwest Pacific Clone) and USA300 
(Figure 1), with a Dice similarity coefficient >80%. The study 
was supplemented with MLST, which detected three different 
strains: ST30, ST8, and ST45, the latter not presenting any 
relation with the clones compared in the PFGE.
Alegre, Brazil, in individuals who do not have traditional risk 
factors for infection by this pathogen.
The first cases of CA-MRSA in Porto Alegre are from 2002 
and 200324, about ten years after the first reports of typical 
community-acquired MRSA in western Australia, which 
infected the local aboriginal population27. Later, another study 
showed the existence of this isolated MRSA in the southeast 
region (Rio de Janeiro)28. The fact that the two geographic areas 
Dice (opt:0.80%) (Tol 2.0%-2.0%) (H>0.0% S>0.0%) [0.0%-100.0%]
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(Porto Alegre and Rio de Janeiro) are separated by about 1,500 
kilometers of distance should indicate that this isolated MRSA 
is found in different regions of the country. 
Our study is pioneering in Brazil in identifying and 
characterizing isolated MRSA found only in skin and soft tissue 
infections. When compared with the results of studies from other 
countries, a great variation in the taxes of prevalence of CA-
MRSA is observed. However, an important observation in all the 
studies is that, since the organism was first found, the prevalence 
of infections caused by CA-MRSA has been increasing. Reports 
from other countries, such as the United States, show that there is 
a great variation in occurrences related to geography. In a study 
done on 11 emergency centers in different cities in the United 
States in August 2004, a global prevalence rate of 59% was 
observed, and the variation found was between 15% and 74%29. 
More recently, in a study done in 10 primary care clinics in Texas, 
United States, Forcade et al.30 detected a similar value: about 61% 
of skin and soft tissue infections caused by CA-MRSA.
A multicenter study conducted in Argentina showed a 
high prevalence of methicillin-resistant Staphylococus aureus 
isolated in infections of children from the community. Among 
the 447 samples analyzed in the years 2006 and 2007, 281 met 
the criteria set for CA-MRSA. This investigation showed that 
62% of isolates came from skin and soft tissue infections31. In 
contrast, in the Nordic countries (Denmark, Finland, Iceland, 
Norway, and Sweden), the rates of infections by MRSA are less 
than 1%; however, in all these countries a significant increase in 
the infection rate was observed in the last 3 to 5 years, possibly 
related to an alteration in the behavior of the isolated MRSA32.
The CA-MRSA isolates obtained in the present study 
showed an increased susceptibility profile to antimicrobial 
agents, although three isolates showed resistance to 
other antimicrobials, such as chloramphenicol (AD554), 
ciprofloxacin and erythromycin (A31652), and erythromycin 
and clindamycin (A31651). The results herein parallel those 
described by Ribeiro et al.28 and Chen et al.33, who reported 
CA-MRSA strains resistant to other non-beta-lactam 
antimicrobials.
The molecular characterization showed the presence of 
clonal type IV in all MRSA isolates. The findings corroborate the 
increased susceptibility to antimicrobials, attributed to SCCmec 
type IV, which is smaller and usually does not aggregate other 
resistance determinants, unlike classical hospital strains. 
The analysis of chromosomal DNA revealed a similarity to the 
OSPC clone in two isolates. Of the two patients infected with 
CA-MRSA similar to the OSPC clone (SCCmec IV, ST30, 
PVL+), one developed severe necrotizing pneumonia (A31656), 
secondary to soft tissue lesions, and was hospitalized for 50 
days. The second patient (A31651) infected with CA-MRSA of 
the same clone showed recurrent furunculosis and was treated 
with first-generation cephalosporin, which provided no cure for 
the infection and lesions. The isolates pertaining to this clone 
showed Panton-Valentine leukocidin-encoding genes, which 
contributed to aggravating the clinical status. The results confirm 
the findings of Ribeiro et al.28 in isolates of skin infections in the 
same Brazilian city. The presence of circulating OSPC clones 
is alarming because an outbreak in the neighboring country, 
Uruguay, was attributed to this very clone, and several patients 
developed severe pneumonia34. Although presenting SCCmec 
IV, ST30, and PVL+, a third isolate (A31655) did not show any 
similarity with the OSPC clone.
Another international clone found in our study was USA300 
(SCCmec IV, ST8, PVL-). Most isolates pertaining to the 
USA300 clone showed PVL-encoding genes18; however, recent 
studies have shown samples that do not produce the toxin28,29. 
The USA300 clone has been reported in many regions of 
the United States, especially among football players and prison 
inmates12,31. A recent study in the United States has shown that 
50% of MRSA isolates from skin and soft tissue infections belong 
to the USA300 clone35.
We emphasize the importance of identification and 
therapeutic practice in infections associated with S. aureus, 
particularly those caused by methicillin-resistant isolates. 
In 1999, four children in the States of Minnesota and North 
Dakota in the United States died from infections caused by 
CA-MRSA36. In these cases, cephalosporins were initially 
used in the treatment, and the delay in using an appropriate 
antimicrobial agent may have contributed to the outcome. 
Another study conducted in the United States showed that 80% 
of patients with skin and soft tissue infections received empirical 
treatment. Of these, 57% did not respond to treatment because 
the microorganism was resistant29. These findings suggest the 
need to reassess the choice of empirical treatments for skin and 
soft tissue infections in areas where MRSA is prevalent in the 
community. In a teaching hospital in California, United States, 
MRSA was detected in 87% of Staphylococcus aureus isolates 
from patients with skin infections treated at its emergency center. 
This study supports the drainage of skin abscesses as a preferred 
treatment as opposed to using antimicrobial agents37. Despite 
controversies concerning the choice of treatment and even of 
the antimicrobial agent for managing skin infections caused by 
S. aureus, cephalosporins are among those with the highest 
utilization rates.
The emergence of Staphylococcus aureus type IV as a 
pathogen associated with community-acquired skin and soft 
tissue infections is remarkable. Another important aspect that 
might prevent the dissemination of this microorganism is the 
certainty that these strains circulate outside the hospital setting. 
Thus, the importance of laboratory cultivation and antimicrobial 
profiling of clinical material from skin and soft tissue infections 
in primary care facilities, such as hospital emergency centers 
and dermatological care centers, is unequivocal. By identifying 
the microorganism and performing a susceptibility test, an 
appropriate treatment that focuses on control measures for this 
pathogen may be implemented.
We described the emergence of community-acquired 
methicillin-resistant Staphylococcus aureus carrying SCCmec 
type IV in two health care centers in Porto Alegre, southern Brazil. 
These observations provide some insight into the epidemiology 
of this pathogen, which is of clinical importance, and add new 
elements to our understanding of the molecular biology of 
infections by CA-MRSA in our country.
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